Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Accord Healthcare S.L.U.

02 12Accord Healthcare Slu

03 16Amgen Technology (Ireland) Unlimited Company

04 11Biosimilar Collaborations Ireland Limited

05 6Celltrion Healthcare Hungary Kft

06 10Celltrion Healthcare Hungary Kft.

07 4Elc Group Sro

08 6Formycon Ag

09 10Fresenius Kabi Deutschland Gmbh

10 3Iqone Healthcare Switzerland Sa

11 3JANSSEN CILAG INTERNAT.N.V.

12 6Janssen - Cilag International

13 6Janssen-Cilag Ag

14 6Janssen-Cilag International N.V.

15 6Janssen-Cilag International NV

16 10Janssen-Cilag International Nv

17 3Samsung Bioepis Ch Gmbh

18 14Samsung Bioepis Nl B.V.

19 6Samsung Bioepis Nl Bv

20 2Spirig Healthcare Ag

21 6Stada Arzneimittel Ag

22 2Stada Pharmaceuticals AG

23 3Stada Pharmaceuticals Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Ustekinumab

Brand Name : Absimky

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 130mg

Packaging :

Approval Date : 12/12/2024

Application Number : 20240408000057

Regulatory Info : Approved

Registration Country : Sweden

blank

02

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Ustekinumab

Brand Name : Absimky

Dosage Form : Solution For Injection

Dosage Strength : 45mg

Packaging :

Approval Date : 12/12/2024

Application Number : 20240408000033

Regulatory Info : Approved

Registration Country : Sweden

blank

03

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Ustekinumab

Brand Name : Absimky

Dosage Form : Solution For Injection

Dosage Strength : 90mg

Packaging :

Approval Date : 12/12/2024

Application Number : 20240408000040

Regulatory Info : Approved

Registration Country : Sweden

blank

04

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Ustekinumab

Brand Name : Fymskipa

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 130mg

Packaging :

Approval Date : 25/09/2024

Application Number : 20230911000040

Regulatory Info : Approved

Registration Country : Sweden

blank

05

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

WR99210

Brand Name : Stelara

Dosage Form : Ustekinumab 45Mg 0,5Ml 1 Unit Parenteral Use

Dosage Strength : 1 vial SC 45 mg 0.5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

WR99210

Brand Name : Stelara

Dosage Form : Ustekinumab 45Mg 0,5Ml 1 Unit Parenteral Use

Dosage Strength : 1 syringe SC 45 mg 0.5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

WR99210

Brand Name : Stelara

Dosage Form : Ustekinumab 90Mg 1Ml 1 Units Parenteral Use

Dosage Strength : 1 syringe SC 90 mg 1 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Ustekinumab

Brand Name : Eksunbi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 130mg

Packaging :

Approval Date : 12/09/2024

Application Number : 20240507000040

Regulatory Info : Approved

Registration Country : Sweden

blank

09

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Ustekinumab

Brand Name : Eksunbi

Dosage Form : Solution For Injection

Dosage Strength : 45mg

Packaging :

Approval Date : 12/09/2024

Application Number : 20240507000026

Regulatory Info : Approved

Registration Country : Sweden

blank

10

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Ustekinumab

Brand Name : Eksunbi

Dosage Form : Solution For Injection

Dosage Strength : 90mg

Packaging :

Approval Date : 12/09/2024

Application Number : 20240507000033

Regulatory Info : Approved

Registration Country : Sweden

blank